Login / Signup

Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study.

Masaru InataniYusuke OriiKentaro IwasakiShogo ArimuraHiromi SunagawaMinako ShiokawaKenji InoueTakuto SakonoTakato SakonoRika KuwamuraAkiko YoshidaJunko OiYasuaki KuwayamaKiyoshi KanoNoriaki KidoAkiko MatsuyamaMineo OzakiHideki AbeChizuru InoueSatoko NakagawaKunihiro MusashiAkiyasu KanamoriJinhee LeeShinichiro OtaniRyota AokiHirotaka TanabeShunsuke NakakuraKatsuyoshi SuzukiTakeshi SagaraYoshiaki SaitoMotoyasu SameshimaMai UrahashiFumika Watanabe-KitamuraToshihiro InoueFumie KagayaYusuke MuraiSotaro MoriKaori UedaTakuji KurimotoYuko Yamada-NakanishiMakoto NakamuraTakehiro YamashitaSosuke IshiyamaShinichi ManabeKeiko TakakiKen HayashiAkiko IshidaAika TsutsuiKaoru ManabeMasaki Tanito
Published in: Advances in therapy (2023)
jRCTs051190125.
Keyphrases
  • double blind
  • clinical trial
  • placebo controlled
  • phase ii
  • phase iii
  • open label
  • study protocol
  • molecular docking
  • structure activity relationship
  • randomized controlled trial